Evolving antimicrobial chemotherapy for Staphylococcus aureus infections:: Our backs to the wall

被引：19

作者：

Daum, RS ^{[1
]}

Seal, JB ^{[1
]}

机构：

[1] Univ Chicago, Dept Pediat, Sect Pediat Infect Dis, Chicago, IL 60637 USA

来源：

CRITICAL CARE MEDICINE | 2001年 / 29卷 / 04期

关键词：

Staphylococcus aureus staphylococci vancomycin glycopeptide streptogramins lysostaphin;

D O I：

10.1097/00003246-200104001-00007

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Staphylococcus aureus is responsible for many nosocomial and community-acquired infections. Its evolving resistance to traditional antimicrobial chemotherapy and emerging prevalence outside of the healthcare environment are serious concerns. This review of the changing epidemiology of methicillin-resistant S, aureus, the emergence of vancomycin (glycopeptide)-resistant isolates, and the mechanisms of resistance to beta -lactams and glycopeptides provides an update for clinicians regarding effective strategies for treatment mechanisms of resistance to beta -lactams and glycopeptides provides an update for clinicians regarding effective strategies for treatment mechanisms of resistance to beta -lactams and glycopeptides provides an update for clinicians regarding effective strategies for treatment.

引用

页码：N92 / N96

页数：5

共 47 条

[1] Clonal features of community-acquired methicillin-resistant Staphylococcus aureus in children [J].

Abi-Hanna, P ;

Frank, AL ;

Quinn, JP ;

Kelkar, S ;

Schreckenberger, PC ;

Hayden, MK ;

Marcinak, JF .

CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) :630-631

[2] Methicillin-resistant Staphylococcus aureus in two child care centers [J].

Adcock, PM ;

Pastor, P ;

Medley, F ;

Patterson, JE ;

Murphy, TV .

JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (02) :577-580

[3]

[Anonymous], 1999, MMWR-MORBID MORTAL W, V48, P707

[4]

[Anonymous], MMWR MORB MORTAL WKL

[5] SYNTHESIS OF PENICILLIN - 6-AMINOPENICILLANIC ACID IN PENICILLIN FERMENTATIONS [J].

BATCHELOR, FR ;

DOYLE, FP ;

NAYLER, JHC ;

ROLINSON, GN .

NATURE, 1959, 183 (4656) :257-258

[6] COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS INFECTION [J].

BERMAN, DS ;

EISNER, W ;

KREISWIRTH, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (25) :1896-1896

[7] Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates [J].

Boyle-Vavra, S ;

Berke, SK ;

Lee, JC ;

Daum, RS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :272-277

[8] A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates [J].

Boyle-Vavra, S ;

Labischinski, H ;

Ebert, CC ;

Ehlert, K ;

Daum, RS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :280-287

[9] LYSOSTAPHIN - ENZYMATIC MODE OF ACTION [J].

BROWDER, HP ;

ZYGMUNT, WA ;

YOUNG, JR ;

TAVORMIN.PA .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1965, 19 (03) :383-&

[10]

CASEWELL MW, 1986, J ANTIMICROB CHEMOTH, V18, P1

← 1 2 3 4 5 →